MOLECULAR BIOLOGY OF PNEUMOCYSTIS CARINII ANTIGENS
卡氏肺囊虫抗原的分子生物学
基本信息
- 批准号:6149248
- 负责人:
- 金额:$ 31.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-08-01 至 2002-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (Adapted from applicant's abstract): Pneumonia caused by the
opportunistic fungus Pneumocystis carinii is a major cause of morbidity and
mortality in the immunocompromised host, including those with AIDS. The
long-range goal of this proposal is to characterize the structure and function
of proteins of importance in the biology of P. carinii and the pathogenesis of
P. carinii Pneumonia (PCP), in order to identify potential targets for therapy
against infection. We will focus on a newly described serine protease of mouse
P. carinii, KEX1. The homology of mouse P. carinii KEX1 to the kexin family of
fungal proteases and the mammalian prohormone convertases (furins) suggests it
may be involved in the proteolytic processing and maturation of other P.
carinii proteins, thereby playing an important role in the biology of P.
carinii. A potential substrate for KEX1 is the adhesive surface antigen of P.
carinii, glycoprotein A (gpA), which must be post-translationally processed to
remove a conserved leader sequence (UCS) prior to placement on the organism's
surface. A lysine-arginine dipeptide sequence recognized by the kexin family of
proteases is found at the UCS-gpA junction in both animal and human P. carinii.
The investigators will test the hypothesis that mouse P. carinii KEX1 can
cleave the mouse P. carinii UCS-gpA junction. They will also characterize
further the molecular biology and substrate specificity of KEX1. The specific
aims of the proposal are: (1) To determine the level of KEX1 RNA and protein
expression in different life cycle forms of mouse P. carinii; (2) To determine
the subcellular location of KEX1 protein in mouse P. carinii; (3) To
investigate functional aspects of mouse P. carinii KEX1; and (4) To
characterize the genomic organization of the mouse P. carinii KEX1 gene. The
proposed studies of mouse P. carinii KEX1 will provide a basis for comparison
to similar enzymes in other members of the P. carinii family. Since all P.
carinii synthesize protein species that must be post-translationally processed,
an understanding of the structure and function of the kexin-like proteases of
P. carinii may lead to the design of specific enzyme inhibitors that would
adversely affect the biological processes of this important pathogen.
描述(改编自申请人摘要):由
机会性真菌卡氏肺孢子虫是发病的主要原因,
免疫功能低下的宿主,包括艾滋病患者的死亡率。的
该提案的长期目标是描述结构和功能
卡氏肺孢子虫生物学中重要的蛋白质和卡氏肺孢子虫的发病机制
卡氏肺孢子虫肺炎(PCP),以确定潜在的治疗靶点
抵抗感染我们将重点研究一种新发现的小鼠丝氨酸蛋白酶
卡氏假单胞菌、KEX1.小鼠卡氏肺孢子虫KEX 1与卡氏肺孢子虫Kexin家族的同源性
真菌蛋白酶和哺乳动物激素原转化酶(弗林蛋白酶)表明,
可能参与其他P.
卡氏原核菌蛋白质,从而在卡氏原核菌生物学中发挥重要作用。
carinii。KEX 1的潜在底物是P的粘附表面抗原。
卡氏梭菌,糖蛋白A(gpA),其必须经过后处理,
在放置在生物体的
面一种由Kexin家族识别的赖氨酸-精氨酸二肽序列,
在动物和人卡氏肺孢子虫的UCS-gpA连接处发现了这种蛋白酶。
研究人员将测试小鼠卡氏肺孢子虫KEX 1可以
切割小鼠卡氏肺孢子虫UCS-gpA连接。他们还将描述
进一步研究了KEX 1的分子生物学和底物特异性。具体
目的:(1)检测KEX 1的RNA和蛋白水平
在小鼠卡氏肺孢子虫不同生活史形式中的表达;(2)确定
KEX 1蛋白在卡氏肺孢子虫中的亚细胞定位
研究小鼠卡氏肺孢子虫KEX 1的功能方面;和(4)为了
表征小鼠卡氏肺孢子虫KEX1基因的基因组结构。的
对小鼠卡氏肺孢子虫KEX 1的拟议研究将为比较提供基础
卡氏肺孢子虫家族其他成员的类似酶。所有P。
卡氏梭菌合成必须进行后处理的蛋白质种类,
了解kexin样蛋白酶的结构和功能,
卡氏肺孢子虫可能导致设计特异性酶抑制剂,
对这种重要病原体的生物过程产生不利影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Constantine G HAIDARIS其他文献
Constantine G HAIDARIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Constantine G HAIDARIS', 18)}}的其他基金
Mechanisms of vulvodynia involving dysregulation of pro-resolving lipids
外阴痛的机制涉及促溶解脂质的失调
- 批准号:
10414893 - 财政年份:2018
- 资助金额:
$ 31.9万 - 项目类别:
Mitochondrial function and antifungal photodynamic therapy
线粒体功能和抗真菌光动力疗法
- 批准号:
8324406 - 财政年份:2011
- 资助金额:
$ 31.9万 - 项目类别:
相似海外基金
Development of a vaccine to prevent Pneumocystis pneumonia
开发预防肺孢子虫肺炎的疫苗
- 批准号:
9906567 - 财政年份:2020
- 资助金额:
$ 31.9万 - 项目类别:
Pathogenesis of spontaneous pneumocystis pneumonia in Caspase8 and Ripk3 double deficient mice
Caspase8和Ripk3双缺陷小鼠自发性肺孢子虫肺炎的发病机制
- 批准号:
19K17650 - 财政年份:2019
- 资助金额:
$ 31.9万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Therapeutic antibodies to treat Pneumocystis pneumonia in a nonhuman primate model of HIV infection
在 HIV 感染的非人灵长类动物模型中治疗肺孢子虫肺炎的治疗性抗体
- 批准号:
10001636 - 财政年份:2018
- 资助金额:
$ 31.9万 - 项目类别:
Therapeutic antibodies to treat Pneumocystis pneumonia in a nonhuman primate model of HIV infection
在 HIV 感染的非人灵长类动物模型中治疗肺孢子虫肺炎的治疗性抗体
- 批准号:
9624861 - 财政年份:2018
- 资助金额:
$ 31.9万 - 项目类别:
Vitamin D as Supplemental Therapy for Pneumocystis Pneumonia
维生素 D 作为肺孢子菌肺炎的补充疗法
- 批准号:
9063354 - 财政年份:2016
- 资助金额:
$ 31.9万 - 项目类别:
Vitamin D as Supplemental Therapy for Pneumocystis Pneumonia
维生素 D 作为肺孢子虫肺炎的补充疗法
- 批准号:
9238656 - 财政年份:2016
- 资助金额:
$ 31.9万 - 项目类别:
Improved Therapeutics and Diagnostics for Pneumocystis Pneumonia
改进肺孢子虫肺炎的治疗和诊断
- 批准号:
10521311 - 财政年份:2016
- 资助金额:
$ 31.9万 - 项目类别:
Improved Therapeutics and Diagnostics for Pneumocystis Pneumonia
改进肺孢子虫肺炎的治疗和诊断
- 批准号:
9210593 - 财政年份:2016
- 资助金额:
$ 31.9万 - 项目类别: